Skip to main content
. 2022 Jan 13;107(10):2329–2343. doi: 10.3324/haematol.2021.279672

Table 2.

Multivariable analysis for overall survival, event-free survival and relapse risk, including proteomic-based signatures.

graphic file with name 1072329.tab2.jpg